RESISTANCE DATA
ZERO PATIENTS DEVELOPED PI RESISTANCE THROUGH 144 WEEKS1
Atazanavir showed a high genetic barrier to resistance regardless of booster in Study 1141
Patients Developing Resistance Through Week 144
Patients Developing Resistance
Through Week 144


r=ritonavir; PI=protease inhibitor; TDF=tenofovir disoproxil fumarate; FTC=emtricitabine.
- 21 patients in the EVOTAZ arm and 19 patients in the REYATAZ/r arm met criteria for resistance testing and had data available1
- Resistance to atazanavir may not preclude the subsequent use of other PIs2
Resistance profile is an important factor in preserving future treatment options